We are live on ! Find out more
Clearstead Advisors

Clearstead Advisors Portfolio holdings

AUM $10.6B Turnover 42.91%
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$7.93B
AUM Growth
+$314M
Cap. Flow
+$949M
Cap. Flow %
11.97%
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
3.3 years
Top 20 Avg Time Held Equity + Options
2.9 years
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
3.4 years
Top 20 Avg Time Held Equity only
2.9 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 60.1%
2 Technology 12.05%
3 Financials 6.74%
4 Industrials 4.89%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CRML icon
3301
Critical Metals Corp
CRML
$1.02B
– –
-725
Closed -$4.51K –
AIRJ icon
3302
Montana Technologies Corp
AIRJ
$235M
– –
-77
Closed -$362 –
DXYZ icon
3303
Destiny Tech100
DXYZ
$884M
– –
-102
Closed -$2.17K –
LPA icon
3304
Logistic Properties of the Americas
LPA
$88.4M
– –
-9
Closed -$42 –
IBTA icon
3305
Ibotta
IBTA
$986M
– –
-57
Closed -$1.59K –
SVCO icon
3306
Silvaco Group
SVCO
$223M
– –
-23
Closed -$125 –
BIOA icon
3307
BioAge Labs
BIOA
$246M
– –
-18
Closed -$106 –
BTX icon
3308
BlackRock Technology and Private Equity Term Trust
BTX
$1.02B
– –
-12,935
Closed -$86.7K –
BWIN icon
3309
Baldwin Insurance Group
BWIN
$4.49B
– –
-659
Closed -$18.6K –
BOW icon
3310
Bowhead Specialty Holdings
BOW
$1.12B
– –
-13
Closed -$352 –
RAPP icon
3311
Rapport Therapeutics
RAPP
$1.42B
– –
-33
Closed -$981 –
WBTN icon
3312
WEBTOON Entertainment Inc
WBTN
$1.21B
– –
-119
Closed -$2.31K –
AIOT icon
3313
PowerFleet Inc
AIOT
$334M
– –
-59
Closed -$310 –
ARDT icon
3314
Ardent Health
ARDT
$1.72B
– –
-142
Closed -$1.88K –
CON icon
3315
Concentra Group Holdings
CON
$4.99B
– –
-13
Closed -$273 –
UCB icon
3316
United Community Banks
UCB
$4.11B
– –
-5
Closed -$157 –
SBC icon
3317
SBC Medical Group
SBC
$545M
– –
-119
Closed -$517 –
UPB icon
3318
Upstream Bio Inc
UPB
$187M
– –
-163
Closed -$3.07K –
PENG icon
3319
Penguin Solutions Inc
PENG
$3.17B
– –
-62
Closed -$1.63K –
ILLR
3320
DELISTED
TRILLER GROUP INC
ILLR
– –
0
– -$1
2025 Q3
1 quarter
HURA icon
3321
TuHURA Biosciences
HURA
$117M
– –
-131
Closed -$325 –
PRMB icon
3322
Primo Brands
PRMB
$6.87B
– –
-189
Closed -$4.18K –
CIRC icon
3323
Circle8 Group
CIRC
$37.4M
– –
-7
Closed -$22 –
NPKI icon
3324
NPK International
NPKI
$906M
– –
-25
Closed -$283 –
MTSR
3325
DELISTED
Metsera Inc
MTSR
– –
-1,867
Closed -$97.7K –

Similar funds

Clearstead Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors deployed $949M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, down from 61% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.

  • Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
  • Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
  • Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
  • Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
  • Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
  • Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.